Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novation, Premier Ban “Up-Front” Administrative Fees In GPO Codes

This article was originally published in The Gray Sheet

Executive Summary

Novation and Premier are implementing their own GPO operating principles to help assuage Senate Judiciary/Antitrust Subcommittee concerns with the Health Industry Group Purchasing Association's code of conduct

You may also be interested in...



Hospitals Bypassing GPOs To Form Sole-Source Deals – Ethicist Hanson

The move to multi-source group purchasing organization contracts has not completely resolved anti-competition issues with vendors, according to Kirk Hanson, executive director of Markkule Center for Applied Ethics, Santa Clara University

Hospitals Bypassing GPOs To Form Sole-Source Deals – Ethicist Hanson

The move to multi-source group purchasing organization contracts has not completely resolved anti-competition issues with vendors, according to Kirk Hanson, executive director of Markkule Center for Applied Ethics, Santa Clara University

Premier ethics

Board agrees to implement 1recommendations of ethicist Kirk Hansen, Markkula Center for Applied Ethics, Santa Clara University, to address allegations of unfair business practices, the GPO announces Oct. 23. "Best practices" identified in Hansen's report include limiting administrative fees and bundling unrelated products. Premier notes that many of Hansen's recommendations are already being followed (2"The Gray Sheet" Aug. 12, 2002, p. 10)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017006

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel